Alps Alpine Co Ltd
TSE:6770
Alps Alpine Co Ltd
TSE:6770
Price:
1 525
JPY
-1.74%
Market Closed
Market Cap:
313.6B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Alps Alpine Co Ltd
1525
-27 (-1.74%)
| 52 Week Range |
1 012
1 639
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Alps Alpine Co Ltd
Balance Sheet
Balance Sheet Decomposition
Alps Alpine Co Ltd
Alps Alpine Co Ltd
| Current Assets | 497.5B |
| Cash & Short-Term Investments | 122.2B |
| Receivables | 165B |
| Other Current Assets | 210.3B |
| Non-Current Assets | 266.7B |
| Long-Term Investments | 69.8B |
| PP&E | 141.3B |
| Intangibles | 25.6B |
| Other Non-Current Assets | 29.9B |
| Current Liabilities | 261.8B |
| Accounts Payable | 96.3B |
| Accrued Liabilities | 25.1B |
| Other Current Liabilities | 140.4B |
| Non-Current Liabilities | 97.8B |
| Long-Term Debt | 61.6B |
| Other Non-Current Liabilities | 36.2B |
Balance Sheet
Alps Alpine Co Ltd
Alps Alpine Co Ltd
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
134 783
|
117 543
|
118 968
|
121 554
|
122 079
|
129 598
|
153 067
|
139 730
|
84 173
|
122 667
|
|
| Cash Equivalents |
134 783
|
117 543
|
118 968
|
121 554
|
122 079
|
129 598
|
153 067
|
139 730
|
84 173
|
122 667
|
|
| Total Receivables |
127 010
|
122 989
|
145 702
|
159 671
|
156 555
|
119 352
|
147 963
|
156 289
|
176 711
|
158 292
|
|
| Accounts Receivables |
127 010
|
122 989
|
145 702
|
159 671
|
156 555
|
119 352
|
147 963
|
156 289
|
176 711
|
158 292
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
85 351
|
87 527
|
89 628
|
96 125
|
95 834
|
100 472
|
95 777
|
133 400
|
165 424
|
163 715
|
|
| Other Current Assets |
25 618
|
26 319
|
25 415
|
22 957
|
28 437
|
19 765
|
28 492
|
29 630
|
40 207
|
46 784
|
|
| Total Current Assets |
372 762
|
354 378
|
379 713
|
400 307
|
402 905
|
369 187
|
425 299
|
459 049
|
466 515
|
491 458
|
|
| PP&E Net |
140 942
|
144 167
|
149 785
|
185 891
|
187 646
|
177 865
|
181 270
|
191 260
|
158 545
|
134 211
|
|
| PP&E Gross |
140 942
|
144 167
|
149 785
|
185 891
|
187 646
|
177 865
|
181 270
|
191 260
|
158 545
|
134 211
|
|
| Accumulated Depreciation |
351 935
|
350 823
|
358 369
|
376 311
|
392 143
|
412 114
|
441 375
|
480 709
|
479 553
|
531 864
|
|
| Intangible Assets |
13 069
|
14 217
|
16 773
|
18 572
|
23 248
|
28 259
|
28 183
|
28 231
|
26 484
|
26 551
|
|
| Long-Term Investments |
31 255
|
37 352
|
37 681
|
25 261
|
37 201
|
30 985
|
40 829
|
46 096
|
66 708
|
71 804
|
|
| Other Long-Term Assets |
12 454
|
12 742
|
19 009
|
39 843
|
24 717
|
19 246
|
18 704
|
18 884
|
18 745
|
29 965
|
|
| Total Assets |
570 482
N/A
|
562 856
-1%
|
602 961
+7%
|
669 874
+11%
|
675 717
+1%
|
625 542
-7%
|
694 285
+11%
|
743 520
+7%
|
736 997
-1%
|
753 989
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
66 259
|
67 420
|
74 197
|
73 764
|
69 596
|
61 781
|
79 932
|
85 243
|
98 547
|
93 964
|
|
| Accrued Liabilities |
29 945
|
26 973
|
27 800
|
30 142
|
28 562
|
26 389
|
34 020
|
28 242
|
25 160
|
27 338
|
|
| Short-Term Debt |
28 479
|
34 917
|
35 550
|
0
|
28 870
|
28 020
|
49 051
|
44 596
|
44 088
|
40 865
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1 878
|
37 408
|
9 921
|
29 583
|
3 256
|
14 425
|
33 218
|
9 677
|
|
| Other Current Liabilities |
45 370
|
49 501
|
48 659
|
56 346
|
51 080
|
52 265
|
58 179
|
61 773
|
63 557
|
75 867
|
|
| Total Current Liabilities |
212 699
|
178 811
|
188 084
|
197 660
|
188 029
|
198 038
|
224 438
|
234 279
|
264 570
|
247 711
|
|
| Long-Term Debt |
45 074
|
19 418
|
25 843
|
35 571
|
73 094
|
47 374
|
71 216
|
62 149
|
44 973
|
79 057
|
|
| Deferred Income Tax |
5 502
|
5 988
|
4 696
|
2 646
|
1 038
|
2 333
|
3 730
|
4 136
|
8 140
|
17 592
|
|
| Minority Interest |
104 079
|
103 088
|
106 365
|
114 362
|
29 652
|
30 872
|
33 244
|
35 701
|
1 565
|
1 648
|
|
| Other Liabilities |
23 507
|
26 875
|
23 224
|
18 125
|
18 196
|
22 182
|
16 522
|
17 648
|
19 532
|
16 805
|
|
| Total Liabilities |
390 861
N/A
|
334 180
-15%
|
348 212
+4%
|
368 364
+6%
|
310 009
-16%
|
300 799
-3%
|
349 150
+16%
|
353 913
+1%
|
338 780
-4%
|
362 813
+7%
|
|
| Equity | |||||||||||
| Common Stock |
23 623
|
38 730
|
38 730
|
38 730
|
38 730
|
38 730
|
38 730
|
38 730
|
38 730
|
38 730
|
|
| Retained Earnings |
108 427
|
143 829
|
172 925
|
214 123
|
227 439
|
206 769
|
198 711
|
217 277
|
222 490
|
184 417
|
|
| Additional Paid In Capital |
42 228
|
57 248
|
56 071
|
56 065
|
126 561
|
126 544
|
124 592
|
124 549
|
124 206
|
124 138
|
|
| Unrealized Security Profit/Loss |
4 929
|
3 420
|
3 973
|
4 229
|
2 698
|
12 939
|
16 562
|
20 307
|
21 852
|
23 897
|
|
| Treasury Stock |
3 506
|
3 505
|
3 493
|
3 497
|
18 283
|
32 233
|
26 396
|
26 219
|
28 581
|
28 365
|
|
| Other Equity |
3 920
|
11 046
|
13 457
|
8 140
|
11 437
|
28 006
|
7 064
|
14 963
|
19 520
|
48 359
|
|
| Total Equity |
179 621
N/A
|
228 676
+27%
|
254 749
+11%
|
301 510
+18%
|
365 708
+21%
|
324 743
-11%
|
345 135
+6%
|
389 607
+13%
|
398 217
+2%
|
391 176
-2%
|
|
| Total Liabilities & Equity |
570 482
N/A
|
562 856
-1%
|
602 961
+7%
|
669 874
+11%
|
675 717
+1%
|
625 542
-7%
|
694 285
+11%
|
743 520
+7%
|
736 997
-1%
|
753 989
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
179
|
196
|
196
|
196
|
211
|
204
|
207
|
207
|
205
|
206
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
